Cabenuva is a long acting HIV treatment that combines cabotegravir and rilpivirine and is administered by a healthcare professional according to an approved treatment schedule. Understanding the dosing process can help people receiving treatment know what to expect during appointments and ongoing HIV care. Treatment schedules may involve monthly or every two month injections after the appropriate initiation process. Healthcare providers consider factors such as treatment history, viral suppression, medication interactions, and individual health needs when planning therapy. Regular appointments and communication with healthcare professionals are important parts of maintaining a consistent HIV treatment schedule.
Cabenuva is a long acting injectable treatment used as part of HIV management for eligible adults who meet specific treatment requirements. It combines two antiretroviral medicines, cabotegravir and rilpivirine, which work to help maintain viral suppression. Unlike daily oral HIV medicines, Cabenuva is administered by a healthcare professional at scheduled visits. Understanding how dosing and treatment schedules work can help patients prepare for appointments and discuss suitable treatment options with their healthcare providers.
Cabenuva treatment is generally considered for people whose HIV infection is already virologically suppressed on a stable antiretroviral regimen and who meet other clinical requirements. Before changing treatment, healthcare providers review a person's treatment history, current viral load, possible medication interactions, and other health factors. The treatment plan is individualized according to approved prescribing guidance and clinical assessment.
Cabenuva is given as intramuscular injections by a trained healthcare professional. The treatment process may include an initiation approach designed to establish the appropriate medication schedule. Some patients may use oral medicines before starting injections when this is considered appropriate, while healthcare providers may also follow other approved initiation approaches depending on current prescribing guidance.
Important aspects of Cabenuva dosing include:
Because HIV treatment needs can vary, the appropriate approach should be determined through ongoing medical evaluation rather than by following a schedule independently.
After treatment initiation, Cabenuva may be administered according to approved monthly or every two month dosing schedules. The selected schedule depends on the treatment plan established by the healthcare provider. Maintaining scheduled appointments is important because consistent dosing supports continued management of HIV infection and helps healthcare professionals monitor treatment.
If an appointment cannot be attended as planned, patients should contact their healthcare provider as soon as possible. Healthcare professionals can assess the situation and determine the appropriate steps for managing a delayed or missed injection. Depending on the timing and individual circumstances, temporary oral therapy or other adjustments may be considered according to current medical guidance.
Key considerations for maintaining a treatment schedule include:
Cabenuva provides a different approach to HIV treatment by replacing a daily oral regimen with scheduled long acting injections for appropriate individuals. However, it is not suitable for every person living with HIV. Regular medical follow up, adherence to scheduled visits, and open communication with healthcare professionals remain important parts of effective HIV care. Treatment recommendations and approved dosing guidance may change over time, so patients should rely on their healthcare team and current prescribing information when making decisions about Cabenuva or other HIV treatment options.